Incidence and Costs of Hypoglycemia among Type II Diabetes Mellitus Patients in Turkey

C. Fidan, F. Salgur, Ozdemir Efe Kul, Y. Bozkuş, G. Eminsoy, Fisun Sozen, A. Kut, E. Oksuz
{"title":"Incidence and Costs of Hypoglycemia among Type II Diabetes Mellitus Patients in Turkey","authors":"C. Fidan, F. Salgur, Ozdemir Efe Kul, Y. Bozkuş, G. Eminsoy, Fisun Sozen, A. Kut, E. Oksuz","doi":"10.37871/jbres1300","DOIUrl":null,"url":null,"abstract":"We aimed to determine the lifetime and one-year incidence of hypoglycemia in adults who had been treated following a diagnosis of Type II Diabetes Mellitus (T2DM), the factors that affected this incidence, and its effect on the use of health care resources. The descriptive cross-sectional cost study included adult T2DM patients who had an outpatient examination. Using a face-to-face interview method, patients were required to complete a questionnaire containing questions about sociodemographic characteristics, T2DM diagnosis and treatment features, and hypoglycemia events. Episode treatment costs of the patients in whom hypoglycemia was observed were calculated as direct cost per episode from the payer perspective. The mean age of the patients (n = 220) was 48.1 ± 11.8 (range 26-79) years, and the mean duration of disease was 4.5 ± 3.0 (range 1-16) years. According to treatment modalities, the frequency of hypoglycemia in the last year was 4.7% in the patients receiving oral antidiabetic drugs and 32.7% in the patients using insulin. In addition, 61.9% of the patients who had a hypoglycemic event in the last year presented to hospital, and 57.7% of these patients were hospitalized because of the hypoglycemic event. The incidence of hypoglycemia was 18 episodes of hypoglycemia per 100 patient years for T2DM patients and 25 severe hypoglycemia episodes per 100 patient years for patients using insulin. Significant predictors of hypoglycemia included insulin therapy (p = 0.000), regular use of medications (p = 0.013), hospitalization in the last year (p = 0.008), and exercise (p = 0.042). The average cost of a hypoglycemic event was calculated as Purchasing Power Parity İn Dollars ($PPP) 1.370.2 ± 1.407.0 (149.8-5,048.8). T2DM complications are the cause of a high economic burden. Hypoglycemia, which is one of these complications, is observed more frequently in patients who receive insulin therapy, who use regular medication, who do not exercise regularly, and who have been hospitalized in the last year.","PeriodicalId":94067,"journal":{"name":"Journal of biomedical research & environmental sciences","volume":"39 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical research & environmental sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37871/jbres1300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We aimed to determine the lifetime and one-year incidence of hypoglycemia in adults who had been treated following a diagnosis of Type II Diabetes Mellitus (T2DM), the factors that affected this incidence, and its effect on the use of health care resources. The descriptive cross-sectional cost study included adult T2DM patients who had an outpatient examination. Using a face-to-face interview method, patients were required to complete a questionnaire containing questions about sociodemographic characteristics, T2DM diagnosis and treatment features, and hypoglycemia events. Episode treatment costs of the patients in whom hypoglycemia was observed were calculated as direct cost per episode from the payer perspective. The mean age of the patients (n = 220) was 48.1 ± 11.8 (range 26-79) years, and the mean duration of disease was 4.5 ± 3.0 (range 1-16) years. According to treatment modalities, the frequency of hypoglycemia in the last year was 4.7% in the patients receiving oral antidiabetic drugs and 32.7% in the patients using insulin. In addition, 61.9% of the patients who had a hypoglycemic event in the last year presented to hospital, and 57.7% of these patients were hospitalized because of the hypoglycemic event. The incidence of hypoglycemia was 18 episodes of hypoglycemia per 100 patient years for T2DM patients and 25 severe hypoglycemia episodes per 100 patient years for patients using insulin. Significant predictors of hypoglycemia included insulin therapy (p = 0.000), regular use of medications (p = 0.013), hospitalization in the last year (p = 0.008), and exercise (p = 0.042). The average cost of a hypoglycemic event was calculated as Purchasing Power Parity İn Dollars ($PPP) 1.370.2 ± 1.407.0 (149.8-5,048.8). T2DM complications are the cause of a high economic burden. Hypoglycemia, which is one of these complications, is observed more frequently in patients who receive insulin therapy, who use regular medication, who do not exercise regularly, and who have been hospitalized in the last year.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
土耳其2型糖尿病患者低血糖的发病率和成本
我们的目的是确定诊断为2型糖尿病(T2DM)后接受治疗的成年人一生和一年的低血糖发生率、影响该发生率的因素及其对卫生保健资源使用的影响。描述性横断面成本研究包括接受门诊检查的成年T2DM患者。采用面对面访谈法,要求患者填写一份问卷,问卷内容包括社会人口学特征、T2DM诊断和治疗特点、低血糖事件等。观察到低血糖的患者的发作治疗费用从付款人的角度计算为每次发作的直接费用。患者平均年龄(n = 220)为48.1±11.8(范围26-79)岁,平均病程为4.5±3.0(范围1-16)年。按治疗方式分,口服降糖药组近一年低血糖发生率为4.7%,胰岛素组近一年低血糖发生率为32.7%。此外,61.9%的患者在过去一年中出现过低血糖事件,其中57.7%的患者因低血糖事件而住院。T2DM患者的低血糖发生率为每100患者年18次,使用胰岛素患者的严重低血糖发生率为每100患者年25次。低血糖的重要预测因素包括胰岛素治疗(p = 0.000)、定期使用药物(p = 0.013)、去年住院(p = 0.008)和运动(p = 0.042)。低血糖事件的平均成本计算为购买力平价İn美元($PPP) 1.370.2±1.407.0(149.8-5,048.8)。2型糖尿病并发症是造成高额经济负担的原因。低血糖是其中一种并发症,在接受胰岛素治疗、定期用药、不经常运动和去年住院的患者中更常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Breastfeeding among Hispanic and Black Women: Barriers and Support. Flood Prevention Raman Spectroscopic Detection of Silicone Leakage in Human Breast and Lymph Node Tissues Characterization and Selection by Optical Absorption and Emission Spectrophotometry of a Series of Red Dyes Capable of Destroying Far UV Rays by Absorption Improving Invasive Breast Cancer Care Using Machine Learning Technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1